The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American Indian ...

Only three of eight patients (38%) with cirrhosis but without ascites (group Ia) showed elevated serum values of CA 125. However, 21 of 22 patients (95%) with cirrhotic ascites (groups Ib and Ic) had ...

CONCLUSION: In patients whose CA-125 level decreases to normal after chemotherapy, a doubling from the upper limit of normal has been shown to predict progression. In those with persistently elevated ...

The molecular evolution of prostate cancer cell line exosomes with passage number. Role of the p38αMAPK in the prognosis and prediction of response to neoadjuvant chemotherapy in locally advanced ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a ...

There is no standard algorithm for following an ovarian cancer patient with no evidence of disease after primary therapy. [21] Available monitoring tests may include physical examinations, serum ...

medical technician gloved hand holding blood sample in tube Study showed that 82% of patients had elevated CA-125 levels at any point during their disease course. Monitoring levels of the biomarker CA ...

DEAR DR. ROACH: I have a history of cancer with an elevated CA-125 level. Recently I had a shingles shot and soon thereafter, my CA-125 level was high. An extensive workup showed up nothing ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to health ...

(RTTNews) - Sutro Biopharma Inc.'s (STRO) interim phase I updated clinical data for a dose-escalation study of antibody drug-conjugate STRO-002 in ovarian cancer has been encouraging. As per the ...

Please provide your email address to receive an email when new articles are posted on . CA-125 is a “useful test” for ovarian cancer in primary care, especially in symptomatic women aged older than 50 ...

About The Study: In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current ...